Plain-English translation of NCT07598383 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new gel called VC005 to see if it can help treat atopic dermatitis (commonly called eczema) in adults. Researchers want to find out whether this medication works better than a placebo (a gel with no active medicine) and what dose works best. About 120 adults will participate at multiple clinic locations.
Atopic dermatitis causes itchy, inflamed skin that significantly impacts quality of life, and current treatments don't work well for everyone. This trial aims to determine whether this new topical gel can offer a safe and effective option for people with mild to moderate eczema.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of three different doses of the new gel or a placebo gel (with no active medicine). You'll apply the assigned gel to your affected skin areas as directed during the study. You'll have multiple clinic visits where researchers will examine your skin, ask about your symptoms, and check for any side effects. The exact length and number of visits will be explained when you enroll.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
China